Business Context and Reporting Period
This Form 8-K filing by iPower Inc. (Nasdaq: IPW) is dated January 2, 2025, with the report signed on January 8, 2025. The filing addresses a regulatory notice regarding the company's continued listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance relative to listing requirements.
- Minimum Bid Price Requirement: $1.00 per share.
- Compliance Period: 180 calendar days (until July 1, 2025).
Material Changes
On January 2, 2025, iPower Inc. received a letter from Nasdaq stating that its common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days between November 15, 2024, and December 31, 2024. This constitutes a failure to satisfy Nasdaq Listing Rule 5550(a)(2).
Outlook, Risks, and Management Commentary
The company has an initial compliance period until July 1, 2025, to regain compliance. To do so, the closing bid price must meet or exceed $1.00 per share for a minimum of ten consecutive trading days. If the company fails to regain compliance by the deadline, it may be eligible for an additional compliance period if it meets other listing standards (excluding the bid price) and intends to cure the deficiency, potentially through a reverse stock split.
Risks and Contingencies:
- There is no assurance the company will regain compliance or maintain other listing requirements.
- Failure to comply during the initial or extended periods may result in delisting.
- The company may appeal a delisting determination to a Nasdaq Hearings Panel.
- Current listing status remains unchanged; the stock continues to trade under the symbol "IPW."
Investor Verification Checklist
- Verify the current closing bid price of IPW stock to assess proximity to the $1.00 threshold.
- Monitor for any announcements regarding a reverse stock split or other capital structure changes intended to cure the deficiency.
- Track the stock price performance over the next 10 consecutive trading days to determine if the company can meet the initial compliance criteria.
- Review future filings for updates on the July 1, 2025, compliance deadline or potential extensions.